Jan Skvarka

Affiliations

  • Director at Zentalis Pharmaceuticals Inc. (ZNTL), 2024-06-21
  • at Monte Rosa Therapeutics Inc. (GLUE), 2024-06-13
  • President And Ceo at Trillium Therapeutics Inc. (TRIL), 2021-11-19
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ZNTL $25.05 5,000 Director 47,970 2023-09-11 Filing
TRIL $9.24 23,802 Officer, Director 0 2021-05-12 Filing
TRIL $9.20 106,698 Officer, Director 0 2021-05-11 Filing
TRIL $15.03 19,581 Officer, Director 0 2021-01-14 Filing
TRIL $15.04 5,419 Officer, Director 0 2021-01-13 Filing